[77] The described examples of liposomes as nanocarriers for the delivery of anti-TB drugs using passive and active targeting, as well as some anti-TB drugs efficiently incorporated in liposomes ...

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state ...

InnoCan Pharma ( ($TSE:INNO) ) has issued an announcement. Innocan Pharma’s subsidiary, BI Sky Global, has completed the Human Repeated Insult ...

This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre.

Emcure Pharmaceuticals Limited, one of India's leading pharma companies announced the inauguration of its state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, ...

Emcure Pharma inaugurates world-class R&D centre in Ahmedabad: Our Bureau, Mumbai Thursday, January 23, 2025, 16:30 Hrs [IST] Emcure Pharmaceuticals Limited, one of India’s lead ...

Ahmedabad: Emcure Pharmaceuticals Limited has announced the inauguration of its state-of-the-art Formulation Research and ...

[76] Targeted delivery of immunoliposomes was examined for cancer therapy (Figure 3E). Cancer cell-targeting antibodies (HER2/neu and CD20 antibodies) were conjugated on the liposomal surface.

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...

Oral Macromolecular Formulation Market To Expand At A 5.2% CAGR To Reach A Valuation Of US$ 31.7 Million By 2034 Explore the Pharmaceutical market's evolution in oral macromolecular drug formulations, ...

JIVA Technologies Inc shares C.JIVA are trading unchanged at $0.20.